Delaware Court Limits Antitrust Claims in 10x Genomics Patent Dispute

In a recent legal development, a Delaware federal court has dismissed portions of the antitrust counterclaims brought against 10x Genomics Inc., a notable business partner of Harvard. The case involves a patent dispute with a competing biotech firm, which is scheduled for trial next month. The decision narrows the scope of the legal challenge faced by 10x Genomics in this contentious intellectual property lawsuit. For further details on the proceedings, consult the article on Law360.